NCT01464086View on ClinicalTrials.gov

LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)

PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

October 27, 2011

Primary Completion Date

March 31, 2017

Study Completion Date

October 9, 2017

Conditions
Li Fraumeni Syndrome
Interventions
OTHER

whole body MRI

whole body MRI at inclusion, one and two years

Trial Locations (1)

94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT01464086 - LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) | Biotech Hunter | Biotech Hunter